REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
6.66
+0.06 (0.91%)
Oct 28, 2026, 10:03 AM EDT - Market open
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $439.65 million as of October 28, 2026. It is the 15,491st most valuable company in the world and the 2,837th biggest in the United States. Its market cap has decreased by 36.10% in one year.
Market Cap
439.65M
Enterprise Value
584.59M
1-Year Change
-36.10%
Global Rank
Country Rank
#2,837 United States
Category
ChartMarket Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $439.65M, a decrease of -41.33%. That is a compound annual growth rate of -4.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 439.65M | -39.69% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BlossomHill Therapeutics | 465.01M |
| Phathom Pharmaceuticals | 455.93M |
| Eupraxia Pharmaceuticals | 450.95M |
| Surrozen | 445.78M |
| AgomAb Therapeutics NV | 445.69M |
| MapLight Therapeutics | 442.94M |
| Faeth Therapeutics | 441.35M |
| Allogene Therapeutics | 431.86M |